Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT)
2003 · British Journal of Cancer · 42 citations
https://doi.org/10.1038/sj.bjc.6600818
A
Anna Maria Anastasi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
514
Citations
13
h-index
18
i10-index
Anna Maria Anastasi is an academic researcher from Alfasigma (Italy). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Radiopharmaceutical Chemistry and Applications & CAR-T cell therapy research. The author has an h-index of 13, co-authored 31 publications.
Papers by this author
worksSelection, affinity maturation, and characterization of a human scFv antibody against CEA protein
2006 · BMC Cancer · 39 citations
https://doi.org/10.1186/1471-2407-6-41
Biochemical and Biological Characterization of a New Oxidized Avidin with Enhanced Tissue Binding Properties
2010 · Journal of Biological Chemistry · 29 citations
https://doi.org/10.1074/jbc.m109.080457
Production and characterisation of a recombinant single-chain anti ErbB2-clavin immunotoxin.
1998 · PubMed · 11 citations
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy
2022 · Molecular Therapy · 0 citations
https://doi.org/10.1016/j.ymthe.2022.02.013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat